Table 2.
CGM outcomes by change in medical visit frequency from prepandemic to pandemic period
Same or increased visit frequency (n = 437, 79%) | Decreased visit frequency (n = 118, 21%) | |||||
---|---|---|---|---|---|---|
Prepandemic | During pandemic | P | Prepandemic | During pandemic | P | |
Mean glucose, mg/dL (mmol/L) | 194 (10.8) | 187 (10.4) | <0.001 | 187 (10.4) | 187 (10.4) | 0.86 |
SD glucose, mg/dL (mmol/L) | 73 (4.06) | 69 (3.83) | <0.001 | 71 (3.94) | 69 (3.83) | 0.03 |
Glucose CV, % | 37.6 | 37.0 | 0.003 | 38.0 | 37.2 | 0.01 |
GMI, % (mmol/mol) | 8.0 (64) | 7.8 (62) | <0.001 | 7.8 (62) | 7.8 (62) | 0.86 |
P < 0.01 was considered significant; these values are in bold.
Abbreviations: CGM, continuous glucose monitor; CV, coefficient of variation; GMI, glucose management indicator.